Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2025-10-29 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Dividend
Interim / Quarterly Report Classification · 95% confidence The document is dated October 29, 2025, and is an outcome of a Board Meeting where the Board approved the unaudited financial statements for the quarter and nine months ended September 30, 2025. It includes detailed financial data such as revenue, expenses, profit before tax, tax expenses, and profit for the period, which are typical components of an interim or quarterly financial report. The document also mentions a limited review report by statutory auditors, which is standard for interim financial statements. Additionally, an interim dividend declaration is included, which is often part of quarterly results announcements. The document is approximately 7,898 characters long, which is sufficient to contain substantive financial data and analysis, not just a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR) as it provides comprehensive financial results for a period shorter than a full fiscal year with actual financial statements and notes. 9M 2025
2025-10-29 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is dated October 29, 2025, and reports the outcome of a Board Meeting held on the same day. It includes approval of unaudited financial statements for the quarter and nine months ended September 30, 2025, which is a typical feature of an Interim / Quarterly Report. The document also contains detailed financial data such as revenue, expenses, profit before tax, tax expenses, and profit for the period, along with notes explaining accounting standards and business segments. The presence of a Limited Review Report by statutory auditors further supports this classification. Additionally, the document declares an interim dividend, which is often included in quarterly reports. The document length (7898 characters) and content indicate it is the actual financial report, not merely an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2025
2025-10-29 English
Please find enclosed outcome of the Board Meeting held on 29th October 2025.
Interim / Quarterly Report Classification · 95% confidence The document is dated October 29, 2025, and reports the outcome of a Board Meeting held on the same day. It includes approval of unaudited financial statements for the quarter and nine months ended September 30, 2025, along with a Limited Review Report. The document also declares an interim dividend and provides detailed financial results for the quarter and nine months, including notes on accounting standards and business segments. The presence of unaudited financial statements and limited review indicates this is a quarterly or interim financial report. The document is about the financial results for a period shorter than a full fiscal year and contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2025
2025-10-29 English
Press Release dated 27th October 2025 enclosed.
Regulatory Filings
2025-10-27 English
Please find enclosed Intimation regarding cessation of Mr. Rachid Ayari as Interim Managing Director.
Regulatory Filings
2025-10-27 English
Press Release
Regulatory Filings
2025-10-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.